Oxford Asset Management’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,341
Closed -$300K 746
2025
Q4
$300K Buy
+8,341
New +$306K 0.11% 300
2020
Q1
Sell
-33,980
Closed -$591K 1264
2019
Q4
$591K Buy
+33,980
New +$578K 0.02% 1150
2019
Q1
Sell
-28,789
Closed -$501K 2000
2018
Q4
$501K Buy
+28,789
New +$431K 0.01% 1198
2018
Q3
Sell
-194,533
Closed -$1.89M 1939
2018
Q2
$1.89M Sell
194,533
-31,587
-14% -$393K 0.04% 700
2018
Q1
$2.25M Buy
+226,120
New +$1.87M 0.05% 512
2016
Q4
Sell
-84,645
Closed -$237K 871
2016
Q3
$237K Sell
84,645
-58,554
-41% -$135K 0.01% 691
2016
Q2
$322K Buy
+143,199
New +$413K 0.01% 645

Other funds holding VCEL

Oxford Asset Management's VCEL Position: Q1 2026 in Review

Oxford Asset Management sold out of Vericel Corp (VCEL) in Q1 2026, closing a stake of 8,341 shares — an estimated $300K sold.

Oxford Asset Management first reported a position in VCEL in Q2 2016 and held it in 7 quarters. The position peaked at $2.25M in Q1 2018. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Oxford Asset Management reported no remaining Vericel Corp position as of Q1 2026 after selling out during the quarter.
  • Oxford Asset Management sold 8,341 Vericel Corp shares in Q1 2026, an estimated $300K.
  • Oxford Asset Management first reported a position in Vericel Corp in Q2 2016 and held it in 7 quarters.
  • Oxford Asset Management's Vericel Corp position peaked at $2.25M in Q1 2018.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.